These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6180172)

  • 41. Biological chelation: 2,3-dimercapto-propanesulfonic acid and meso-dimercaptosuccinic acid.
    Aposhian HV
    Adv Enzyme Regul; 1982; 20():301-19. PubMed ID: 6287818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent advance in the therapy of metal poisonings with chelating agents.
    Aaseth J
    Hum Toxicol; 1983 Apr; 2(2):257-72. PubMed ID: 6345341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unanswered questions in metal chelation.
    Kosnett MJ
    J Toxicol Clin Toxicol; 1992; 30(4):529-47. PubMed ID: 1331492
    [No Abstract]   [Full Text] [Related]  

  • 44. Lack of effectiveness of D-penicillamine in experimental arsenic poisoning.
    Kreppel H; Reichl FX; Forth W; Fichtl B
    Vet Hum Toxicol; 1989 Feb; 31(1):1-5. PubMed ID: 2540587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. INCREASED BRAIN UPTAKE OF MERCURY CAUSED BY 2,3-DIMERCAPTOPROPANOL (BAL) IN MICE GIVEN MERCURIC CHLORIDE.
    BERLIN M; LEWANDER T
    Acta Pharmacol Toxicol (Copenh); 1965; 22():1-7. PubMed ID: 14254788
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of succimer on the intensity of tricarboxylic acid dehydrogenase reactions in the brain of rats poisoned with mercuric chloride].
    Eshchenko NK; Okonishnikova IE; Putilina FE
    Nerv Sist; 1978; 18():59-67. PubMed ID: 216939
    [No Abstract]   [Full Text] [Related]  

  • 47. Intramuscular administration of iron during long-term chelation therapy with 2,3-dimercaptosuccinic acid in a man with severe lead poisoning.
    Haust HL; Inwood M; Spence JD; Poon HC; Peter F
    Clin Biochem; 1989 Jun; 22(3):189-96. PubMed ID: 2544323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mercury binding to the chelation therapy agents DMSA and DMPS and the rational design of custom chelators for mercury.
    George GN; Prince RC; Gailer J; Buttigieg GA; Denton MB; Harris HH; Pickering IJ
    Chem Res Toxicol; 2004 Aug; 17(8):999-1006. PubMed ID: 15310232
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chelation of lead by dimercaptopropane sulfonate and a possible diagnostic use.
    Twarog T; Cherian MG
    Toxicol Appl Pharmacol; 1984 Mar; 72(3):550-6. PubMed ID: 6710504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DMPS and N-acetylcysteine induced renal toxicity in mice exposed to mercury.
    Brandão R; Santos FW; Zeni G; Rocha JB; Nogueira CW
    Biometals; 2006 Aug; 19(4):389-98. PubMed ID: 16841248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of succimer on the intensity of pyruvate and lactate oxidation in the brains of rats poisoned with mercuric chloride].
    Eshchenko ND; Okonishnikova IE; Putillina FE
    Nerv Sist; 1976; 17():136-44. PubMed ID: 1028934
    [No Abstract]   [Full Text] [Related]  

  • 52. N-acetylcysteine pretreatment ameliorates mercuric chloride-induced oxidative renal damage in rats.
    Ekor M; Adesanoye OA; Farombi EO
    Afr J Med Med Sci; 2010 Dec; 39 Suppl():153-60. PubMed ID: 22416658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of dimercaptosuccinic acid per os on distribution and excretion of 210Pb and 203Hg in mice].
    Liang YY; Zhang JS; Tao ZQ; Yan XM; Xu XH; Chen ZJ
    Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):379-82. PubMed ID: 7801787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fatal mercury poisoning and chelating agents.
    Guzzi G; Minoia C; Ronchi A; Pigatto P
    Forensic Sci Int; 2010 Oct; 202(1-3):e61. PubMed ID: 20537473
    [No Abstract]   [Full Text] [Related]  

  • 55. Protective effects of chelating agents against renal toxicity of gold sodium thiomalate in rats.
    Kojima S; Takahashi Y; Kiyozumi M; Tagawa Y
    Arch Toxicol; 1991; 65(7):532-6. PubMed ID: 1664200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extracorporeal regional complexing haemodialysis treatment of acute inorganic mercury intoxication.
    Kostyniak PJ; Greizerstein HB; Goldstein J; Lachaal M; Reddy P; Clarkson TW; Walshe J; Cunningham E
    Hum Exp Toxicol; 1990 May; 9(3):137-41. PubMed ID: 2165415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical observations on treatment of alkylmercury poisoning in hospital patients.
    Bakir F; Al-Khalidi A; Clarkson TW; Greenwood R
    Bull World Health Organ; 1976; 53 Suppl(Suppl):87-92. PubMed ID: 1086170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity.
    Miller AL
    Altern Med Rev; 1998 Jun; 3(3):199-207. PubMed ID: 9630737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical efficacy of dimercapto-chelating agents against lewisite-induced skin lesions in SKH-1 hairless mice.
    Mouret S; Wartelle J; Emorine S; Bertoni M; Nguon N; Cléry-Barraud C; Dorandeu F; Boudry I
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):291-8. PubMed ID: 23806213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pretreatment with p-aminohippurate inhibits the renal uptake and accumulation of injected inorganic mercury in the rat.
    Zalups RK; Barfuss DW
    Toxicology; 1995 Nov; 103(1):23-35. PubMed ID: 8525487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.